These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
|
|
|
||
|
(Exact name of registrant as specified in its charter)
|
||
|
|
|
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
|
incorporation or organization)
|
Identification No.)
|
|
|
|
||
|
|
||
|
(Address of principal executive offices) (Zip Code)
|
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
|
Name of each exchange on which registered
|
|
None
|
None
|
|
Large accelerated filer
□
|
Accelerated filer
□
|
|
|
|
|
|
Smaller reporting company
|
|
|
|
|
|
Emerging growth company
|
|
Part I. Financial Information
|
4
|
|
Item 1. Financial Statements
|
4
|
|
Condensed Consolidated Balance Sheets
|
4
|
|
Condensed Consolidated Statements of Operations
|
5
|
|
Condensed Consolidated Statements of Comprehensive Income (Loss)
|
6
|
|
Condensed Consolidated Statements of Shareholders’ Equity
|
7
|
|
Condensed Consolidated Statements of Cash Flows
|
9
|
|
Notes to Condensed Consolidated Financial Statements
|
10
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
27
|
|
Item 4. Controls and Procedures
|
34
|
|
Part II. Other Information
|
34
|
|
Item 1. Legal Proceedings
|
34
|
|
Item 1A. Risk Factors
|
34
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
34
|
|
Item 3. Defaults Upon Senior Securities
|
34
|
|
Item 4. Mine Safety Disclosures
|
34
|
|
Item 5. Other Information
|
34
|
|
Item 6. Exhibits
|
34
|
|
Signatures
|
35
|
|
|
June 30, 2025
|
December 31, 2024*
|
||||||
|
ASSETS
|
||||||||
|
Investments:
|
||||||||
|
Investments, available for sale:
|
||||||||
|
Fixed maturities, at fair value (amortized cost $
|
$
|
|
$
|
|
||||
|
Held to maturity redeemable preferred stock, at amortized cost
|
|
|
||||||
|
Equity securities, at fair value (cost $
|
|
|
||||||
|
Equity securities, at cost
|
|
|
||||||
|
Mortgage loans on real estate, at amortized cost (net of credit loss reserve of $
|
|
|
||||||
|
Investment real estate, net
|
|
|
||||||
|
Notes receivable (net of credit loss reserve of $
|
|
|
||||||
|
Policy loans
|
|
|
||||||
|
Short-term investments
|
|
|
||||||
|
Total investments
|
|
|
||||||
|
Cash and cash equivalents
|
|
|
||||||
|
Accrued investment income
|
|
|
||||||
|
Reinsurance receivables:
|
||||||||
|
Future policy benefits
|
|
|
||||||
|
Policy claims and other benefits
|
|
|
||||||
|
Cost of insurance acquired
|
|
|
||||||
|
Income tax receivable
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
|
Liabilities:
|
||||||||
|
Policy liabilities and accruals:
|
||||||||
|
Future policyholder benefits
|
$
|
|
$
|
|
||||
|
Policy claims and benefits payable
|
|
|
||||||
|
Other policyholder funds
|
|
|
||||||
|
Dividend and endowment accumulations
|
|
|
||||||
|
Deferred income taxes
|
|
|
||||||
|
Other liabilities
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
Shareholders' equity:
|
||||||||
|
Common stock -
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Retained earnings
|
|
|
||||||
|
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
|
Total UTG shareholders' equity
|
|
|
||||||
|
Noncontrolling interest
|
|
|
||||||
|
Total shareholders' equity
|
|
|
||||||
|
Total liabilities and shareholders' equity
|
$
|
|
$
|
|
||||
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||||||
|
June 30,
|
June 30,
|
June 30,
|
June 30,
|
|||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Revenue:
|
(as restated)
|
(as restated)
|
||||||||||||||
|
Premiums and policy fees
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Ceded reinsurance premiums and policy fees
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Net investment income
|
|
|
|
|
||||||||||||
|
Other income
|
|
|
|
|
||||||||||||
|
Revenue before net investment gains (losses)
|
|
|
|
|
||||||||||||
|
Net investment gains:
|
||||||||||||||||
|
Other realized investment gains, net
|
|
|
|
|
||||||||||||
|
Change in fair value of equity securities
|
(
|
)
|
|
|
|
|||||||||||
|
Total net investment gains (losses)
|
(
|
)
|
|
|
|
|||||||||||
|
Total revenue
|
|
|
|
|
||||||||||||
|
Benefits and other expenses:
|
||||||||||||||||
|
Benefits, claims and settlement expenses:
|
||||||||||||||||
|
Life
|
|
|
|
|
||||||||||||
|
Ceded reinsurance benefits and claims
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Annuity
|
|
|
|
|
||||||||||||
|
Dividends to policyholders
|
|
|
|
|
||||||||||||
|
Commissions and amortization of deferred policy acquisition costs
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Amortization of cost of insurance acquired
|
|
|
|
|
||||||||||||
|
Operating expenses
|
|
|
|
|
||||||||||||
|
Interest expense
|
|
|
|
|
||||||||||||
|
Total benefits and other expenses
|
|
|
|
|
||||||||||||
|
Income before income taxes
|
(
|
)
|
|
|
|
|||||||||||
|
Income tax expense (benefit)
|
(
|
)
|
|
|
|
|||||||||||
|
Net income (loss)
|
(
|
)
|
|
|
|
|||||||||||
|
Net income attributable to noncontrolling interests
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Net income attributable to common shareholders
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||
|
Amounts attributable to common shareholders
|
||||||||||||||||
|
Basic income per share
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||
|
Diluted income per share
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||
|
Basic weighted average shares outstanding
|
|
|
|
|
||||||||||||
|
Diluted weighted average shares outstanding
|
|
|
|
|
||||||||||||
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||||||
|
June 30,
|
June 30,
|
June 30,
|
June 30,
|
|||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
(as restated)
|
(as restated)
|
|||||||||||||||
|
Net income (loss)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||
|
Other comprehensive income (loss):
|
||||||||||||||||
|
Unrealized holding gains (losses) arising during period, pre-tax
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Tax (expense) benefit on unrealized holding gains (losses) arising during the period
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
Unrealized holding gains (losses) arising during period, net of tax
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Less reclassification adjustment for gains included in net income (loss)
|
|
|
|
|
||||||||||||
|
Tax expense for gains included in net income (loss)
|
|
|
|
|
||||||||||||
|
Reclassification adjustment for gains included in net income (loss), net of tax
|
|
|
|
|
||||||||||||
|
Subtotal: Other comprehensive income (loss), net of tax
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Comprehensive income (loss)
|
(
|
)
|
|
|
|
|||||||||||
|
Less comprehensive income attributable to noncontrolling interests
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Comprehensive income attributable to UTG, Inc.
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||
|
Three Months Ended June 30, 2025
|
Common Stock
|
Additional Paid-In Capital
|
Retained Earnings
|
Accumulated Other
Comprehensive Income (Loss)
|
Noncontrolling Interest
|
Total Shareholders’ Equity
|
||||||||||||||||||
|
Balance at April 1, 2025
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||
|
Common stock issued during year
|
|
|
|
|
|
|
||||||||||||||||||
|
Treasury shares acquired
|
(
|
)
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||
|
Net income attributable to common shareholders
|
|
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||
|
Unrealized holding gain on securities net of noncontrolling interest and reclassification adjustment and taxes
|
|
|
|
|
|
|
||||||||||||||||||
|
Gain attributable to noncontrolling interest
|
|
|
|
|
|
|
||||||||||||||||||
|
Balance at June 30, 2025
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||
|
Six Months Ended June 30, 2025
|
Common Stock
|
Additional Paid-In Capital
|
Retained Earnings
|
Accumulated Other
Comprehensive Income (Loss)
|
Noncontrolling Interest
|
Total Shareholders’ Equity
|
||||||||||||||||||
|
Balance at January 1, 2025
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||
|
Common stock issued during year
|
|
|
|
|
|
|
||||||||||||||||||
|
Treasury shares acquired
|
(
|
)
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||
|
Net income attributable to common shareholders
|
|
|
|
|
|
|
||||||||||||||||||
|
Unrealized holding gain on securities net of noncontrolling interest and reclassification adjustment and taxes
|
|
|
|
|
|
|
||||||||||||||||||
|
Gain attributable to noncontrolling interest
|
|
|
|
|
|
|
||||||||||||||||||
|
Balance at June 30, 2025
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||
|
Three Months Ended June 30, 2024 (as restated)
|
Common Stock
|
Additional Paid-In Capital
|
Retained Earnings
|
Accumulated Other
Comprehensive Income
(Loss)
|
Noncontrolling Interest
|
Total Shareholders’ Equity
|
||||||||||||||||||
|
Balance at April 1, 2024
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||
|
Common stock issued during year
|
|
|
|
|
|
|
||||||||||||||||||
|
Treasury shares acquired
|
(
|
)
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||
|
Net income attributable to common shareholders
|
|
|
|
|
|
|
||||||||||||||||||
|
Unrealized holding loss on securities net of noncontrolling interest and reclassification adjustment and taxes
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
|
Gain attributable to noncontrolling interest
|
|
|
|
|
|
|
||||||||||||||||||
|
Balance at June 30, 2024
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||
|
Six Months Ended June 30, 2024 (as restated)
|
Common Stock
|
Additional Paid-In Capital
|
Retained Earnings
|
Accumulated Other
Comprehensive Income (Loss)
|
Noncontrolling Interest
|
Total Shareholders’ Equity
|
||||||||||||||||||
|
Balance at January 1, 2024
|
|
|
|
(
|
)
|
|
|
|||||||||||||||||
|
Common stock issued during year
|
|
|
|
|
|
|
||||||||||||||||||
|
Treasury shares acquired
|
(
|
)
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||
|
Net loss attributable to common shareholders
|
|
|
|
|
|
|
||||||||||||||||||
|
Unrealized holding loss on securities net of noncontrolling interest and reclassification adjustment and taxes
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
|
Gain attributable to noncontrolling interest
|
|
|
|
|
|
|
||||||||||||||||||
|
Balance at June 30, 2024
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||
|
|
Six Months Ended
|
|||||||
|
June 30,
|
June 30,
|
|||||||
|
2025
|
2024
|
|||||||
|
Cash flows from operating activities:
|
(as restated)
|
|||||||
|
Net income
|
$
|
|
$
|
|
||||
|
Adjustments to reconcile net income to net cash used in operating activities:
|
||||||||
|
Amortization (accretion) of investments
|
|
(
|
)
|
|||||
|
Realized investment gains, net
|
(
|
)
|
(
|
)
|
||||
|
Change in fair value of equity securities
|
(
|
)
|
(
|
)
|
||||
|
Unrealized trading losses included in income
|
|
|
||||||
|
Amortization of cost of insurance acquired
|
|
|
||||||
|
Provision for deferred income taxes
|
|
|
||||||
|
Depreciation and depletion
|
|
|
||||||
|
Stock-based compensation
|
|
|
||||||
|
Charges for mortality and administration of universal life and annuity products
|
(
|
)
|
(
|
)
|
||||
|
Interest credited to account balances
|
|
|
||||||
|
Change in accrued investment income
|
|
|
||||||
|
Change in reinsurance receivables
|
|
|
||||||
|
Change in policy liabilities and accruals
|
(
|
)
|
(
|
)
|
||||
|
Change in income taxes receivable
|
(
|
)
|
|
|||||
|
Change in other assets and liabilities, net
|
(
|
)
|
(
|
)
|
||||
|
Net cash used in operating activities
|
(
|
)
|
(
|
)
|
||||
|
Cash flows from investing activities:
|
||||||||
|
Proceeds from investments sold and matured:
|
||||||||
|
Fixed maturities available for sale
|
|
|
||||||
|
Equity securities
|
|
|
||||||
|
Trading securities
|
|
|
||||||
|
Mortgage loans
|
|
|
||||||
|
Notes receivable
|
|
|
||||||
|
Real estate
|
|
|
||||||
|
Policy loans
|
|
|
||||||
|
Short-term investments
|
|
|
||||||
|
Total proceeds from investments sold and matured
|
|
|
||||||
|
Cost of investments acquired:
|
||||||||
|
Fixed maturities available for sale
|
(
|
)
|
|
|||||
|
Equity securities
|
(
|
)
|
(
|
)
|
||||
|
Trading securities
|
|
(
|
)
|
|||||
|
Mortgage loans
|
(
|
)
|
(
|
)
|
||||
|
Notes receivable
|
(
|
)
|
(
|
)
|
||||
|
Real estate
|
(
|
)
|
(
|
)
|
||||
|
Policy loans
|
(
|
)
|
(
|
)
|
||||
|
Short-term investments
|
|
(
|
)
|
|||||
|
Total cost of investments acquired
|
(
|
)
|
(
|
)
|
||||
|
Net cash (used in) provided by investing activities
|
(
|
)
|
|
|||||
|
Cash flows from financing activities:
|
||||||||
|
Policyholder contract deposits
|
|
|
||||||
|
Policyholder contract withdrawals
|
(
|
)
|
(
|
)
|
||||
|
Payments of principal on notes payable/line of credit
|
|
(
|
)
|
|||||
|
Purchase of treasury stock
|
(
|
)
|
(
|
)
|
||||
|
Net cash used in financing activities
|
(
|
)
|
(
|
)
|
||||
|
Net decrease in cash and cash equivalents
|
(
|
)
|
(
|
)
|
||||
|
Cash and cash equivalents at beginning of period
|
|
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
|
$
|
|
||||
|
June 30, 2025
|
Original or Amortized Cost
|
Gross Unrealized Gains
|
Gross Unrealized Losses
|
Fair Value
|
||||||||||||
|
U.S. Government and govt. agencies and authorities
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
U.S. special revenue and assessments
|
|
|
(
|
)
|
|
|||||||||||
|
All other corporate bonds
|
|
|
(
|
)
|
|
|||||||||||
|
Total fixed maturities, at fair value
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
Held to maturity redeemable preferred stock, at amortized cost
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
December 31, 2024
|
Original or Amortized Cost
|
Gross Unrealized Gains
|
Gross Unrealized Losses
|
Fair Value
|
||||||||||||
|
U.S. Government and govt. agencies and authorities
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
U.S. special revenue and assessments
|
|
|
(
|
)
|
|
|||||||||||
|
All other corporate bonds
|
|
|
(
|
)
|
|
|||||||||||
|
Total fixed maturities, at fair value
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
Held to maturity redeemable preferred stock, at amortized cost
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Fixed Maturity Securities
June 30, 2025
|
Amortized Cost
|
Fair Value
|
||||||
|
Due in one year or less
|
$
|
|
$
|
|
||||
|
Due after one year through five years
|
|
|
||||||
|
Due after five years through ten years
|
|
|
||||||
|
Due after ten years
|
|
|
||||||
|
Total
|
$
|
|
$
|
|
||||
|
June 30, 2025
|
Less than 12 months
|
12 months or longer
|
Total
|
|||||||||||||||||||||
|
Fair value
|
Unrealized losses
|
Fair value
|
Unrealized losses
|
Fair value
|
Unrealized losses
|
|||||||||||||||||||
|
U.S. Government and govt. agencies and authorities
|
$
|
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
||||||||||||
|
U.S. Special Revenue and Assessments
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
|
All other corporate bonds
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
|
Total fixed maturities
|
$
|
|
(
|
)
|
|
(
|
)
|
|
$
|
(
|
)
|
|||||||||||||
|
December 31, 2024
|
Less than 12 months
|
12 months or longer
|
Total
|
|||||||||||||||||||||
|
Fair value
|
Unrealized losses
|
Fair value
|
Unrealized losses
|
Fair value
|
Unrealized losses
|
|||||||||||||||||||
|
U.S. Government and govt. agencies and authorities
|
$
|
|
(
|
)
|
|
(
|
)
|
|
$
|
(
|
)
|
|||||||||||||
|
U.S. special revenue and assessments
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
|
All other corporate bonds
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||
|
Total fixed maturities
|
$
|
|
(
|
)
|
|
(
|
)
|
|
$
|
(
|
)
|
|||||||||||||
|
|
Less than 12 months
|
12 months or longer
|
Total
|
|||||||||
|
As of
June 30, 2025
|
||||||||||||
|
Fixed maturities
|
|
|
|
|||||||||
|
As of December 31, 2024
|
||||||||||||
|
Fixed maturities
|
|
|
|
|||||||||
|
|
June 30, 2025
|
December 31, 2024
|
||||||
|
Unrealized appreciation (depreciation) on available-for-sale securities
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Deferred income taxes
|
|
|
||||||
|
Net unrealized appreciation (depreciation) on available-for-sale securities
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
|
2025
|
2024
|
||||||||||||||
|
Maximum rate
|
Minimum rate
|
Maximum rate
|
Minimum rate
|
|||||||||||||
|
Farm Loans
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
Commercial Loans
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
Residential Loans
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
June 30, 2025
|
December 31, 2024
|
||||
|
In good standing
|
$
|
|
$
|
|
|
|
Total mortgage loans
|
$
|
|
$
|
|
|
|
|
June 30, 2025
|
December 31, 2024
|
||||||
|
Farm
|
$
|
|
$
|
|
||||
|
Commercial
|
|
|
||||||
|
Residential
|
|
|
||||||
|
Total mortgage loans
|
|
|
||||||
|
Less allowance for credit losses
|
(
|
)
|
(
|
)
|
||||
|
Total mortgage loans, net
|
$
|
|
$
|
|
||||
|
|
June 30, 2025
|
December 31, 2024
|
||||||
|
Notes receivable
|
$
|
|
$
|
|
||||
|
Less allowance for credit losses
|
(
|
)
|
(
|
)
|
||||
|
Total notes receivable, net
|
$
|
|
$
|
|
||||
|
Allowance For Credit Losses
|
|||||||||
|
Mortgage
|
Notes
|
Unfunded
|
|||||||
|
Loans
|
Receivable
|
Commitments
|
Total
|
||||||
|
January 1, 2024
|
$
|
|
|
|
$
|
|
|||
|
2024 Change in allowance
|
(
|
(
|
(
|
(
|
|||||
|
December 31, 2024
|
|
|
|
|
|||||
|
2025 Change in allowance
|
(
|
|
|
(
|
|||||
|
June 30, 2025
|
$
|
|
|
|
$
|
|
|||
|
|
June 30, 2025
|
December 31, 2024
|
||||||
|
Raw land
|
$
|
|
$
|
|
||||
|
Commercial
|
|
|
||||||
|
Residential
|
|
|
||||||
|
Land, minerals and royalty interests
|
|
|
||||||
|
Total investment real estate
|
$
|
|
$
|
|
||||
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Realized gains:
|
||||||||||||||||
|
Sales of fixed maturities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Sales of equity securities
|
|
|
|
|
||||||||||||
|
Sales of real estate
|
|
|
|
|
||||||||||||
|
Sales of short-term investments
|
|
|
|
|
||||||||||||
|
Total realized gains
|
|
|
|
|
||||||||||||
|
Realized losses:
|
||||||||||||||||
|
Sales of equity securities
|
|
|
|
|
||||||||||||
|
Sales of short-term investments
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Total realized losses
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Net realized investment gains
|
|
|
|
|
||||||||||||
|
Change in fair value of equity securities:
|
||||||||||||||||
|
Change in fair value of equity securities held at the end of the period
|
(
|
)
|
|
|
|
|||||||||||
|
Change in fair value of equity securities
|
(
|
)
|
|
|
|
|||||||||||
|
Net investment gains
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||
|
Change in net unrealized gains (losses) on available-for-sale investments included in other comprehensive income:
|
||||||||||||||||
|
Fixed maturities
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||
|
Net increase (decrease)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||
|
June 30, 2025
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
|
Fixed maturity securities:
|
||||||||||||||||
|
U.S. Government and government agencies and authorities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
U.S. special revenue and assessments
|
|
|
|
|
||||||||||||
|
Corporate securities
|
|
|
|
|
||||||||||||
|
Total fixed maturities
|
|
|
|
|
||||||||||||
|
Equity securities:
|
||||||||||||||||
|
Common stocks
|
|
|
|
|
||||||||||||
|
Limited liability companies
|
|
|
|
|
||||||||||||
|
Total equity securities
|
|
|
|
|
||||||||||||
|
Short-term investments
|
|
|
|
|
||||||||||||
|
Total financial assets
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
December 31, 2024
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
|
Fixed maturity securities:
|
||||||||||||||||
|
U.S. Government and government agencies and authorities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
U.S. special revenue and assessments
|
|
|
|
|
||||||||||||
|
Corporate securities
|
|
|
|
|
||||||||||||
|
Total fixed maturities
|
|
|
|
|
||||||||||||
|
Equity securities:
|
||||||||||||||||
|
Common stocks
|
|
|
|
|
||||||||||||
|
Limited liability companies
|
|
|
|
|
||||||||||||
|
Total equity securities
|
|
|
|
|
||||||||||||
|
Short-term investments
|
|
|
|
|
||||||||||||
|
Total financial assets
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Investments in
|
||||||||||||
|
|
Investments in Common Stocks
|
Limited Liability Companies
|
Total
|
|||||||||
|
Balance at December 31, 2024
|
$
|
|
$
|
|
$
|
|
||||||
|
Unrealized gains
|
|
|
|
|||||||||
|
Balance at June 30, 2025
|
$
|
|
$
|
|
$
|
|
||||||
|
Investments in
|
||||||
|
Investments in Common Stocks
|
Limited Liability Companies
|
Total
|
||||
|
Balance at December 31, 2023
|
$
|
|
$
|
|
$
|
|
|
Unrealized gains
|
|
|
|
|||
|
Purchases
|
|
|
|
|||
|
Sales
|
|
(
|
(
|
|||
|
Balance at December 31, 2024
|
$
|
|
$
|
|
$
|
|
|
Financial Assets
|
Fair Value at
June 30, 2025
|
Fair Value at
December 31, 2024
|
Valuation Technique
|
||||||
|
Common stocks
|
$
|
|
$
|
|
Pricing Model
|
||||
|
Limited liability companies
|
|
|
Pricing Model
|
||||||
|
Total
|
$
|
|
$
|
|
|||||
|
Investment Category
|
Fair Value at
June 30, 2025
|
Unfunded Commitments
|
Redemption Frequency
|
Redemption Notice Period
|
||||||||||||
|
Redeemable
|
||||||||||||||||
|
Limited partnership
|
$
|
|
$
|
|
|
|
||||||||||
|
Non-redeemable
|
||||||||||||||||
|
Limited liability companies
|
|
|
n/a
|
n/a
|
||||||||||||
|
Limited partnerships
|
|
|
n/a
|
n/a
|
||||||||||||
|
Total
|
$
|
|
$
|
|
||||||||||||
|
Investment Category
|
Fair Value at December 31, 2024
|
Unfunded Commitments
|
Redemption Frequency
|
Redemption Notice Period
|
||||||||||||
|
Redeemable
|
||||||||||||||||
|
Limited partnership
|
$
|
|
$
|
|
|
|
||||||||||
|
Non-redeemable
|
||||||||||||||||
|
Limited liability companies
|
|
|
n/a
|
n/a
|
||||||||||||
|
Limited partnerships
|
|
|
n/a
|
n/a
|
||||||||||||
|
Total
|
$
|
|
$
|
|
||||||||||||
|
|
Carrying
|
Estimated
|
||||||||||||||||||
|
June 30, 2025
|
Amount
|
Fair Value
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||||
|
Assets
|
||||||||||||||||||||
|
Held to maturity redeemable preferred stock
|
$
|
|
|
|
|
|
||||||||||||||
|
Equity securities, at cost
|
|
|
|
|
|
|||||||||||||||
|
Mortgage loans on real estate
|
|
|
|
|
|
|||||||||||||||
|
Notes receivable
|
|
|
|
|
|
|||||||||||||||
|
Policy loans
|
|
|
|
|
|
|||||||||||||||
|
Accrued investment income
|
|
|
|
|
|
|||||||||||||||
|
Liabilities
|
||||||||||||||||||||
|
Policy claims and benefits payable
|
|
|
|
|
|
|||||||||||||||
|
Dividend and endowment accumulations
|
|
|
|
|
|
|||||||||||||||
|
|
Carrying
|
Estimated
|
||||||||||||||||||
|
December 31, 2024
|
Amount
|
Fair Value
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||||
|
Assets
|
||||||||||||||||||||
|
Held to maturity redeemable preferred stock
|
$
|
|
|
|
|
|
||||||||||||||
|
Equity securities, at cost
|
|
|
|
|
|
|||||||||||||||
|
Mortgage loans on real estate
|
|
|
|
|
|
|||||||||||||||
|
Notes receivable
|
|
|
|
|
|
|||||||||||||||
|
Policy loans
|
|
|
|
|
|
|||||||||||||||
|
Accrued investment income
|
|
|
|
|
|
|||||||||||||||
|
Liabilities
|
||||||||||||||||||||
|
Policy claims and benefits payable
|
|
|
|
|
|
|||||||||||||||
|
Dividend and endowment accumulations
|
|
|
|
|
|
|||||||||||||||
|
Instrument
|
Issue Date
|
Maturity Date
|
Revolving
Credit Limit
|
December 31, 2024
|
Borrowings
|
Repayments
|
June 30, 2025
|
||||||||||
|
Line of Credit:
|
|||||||||||||||||
|
UG - CMA
|
|
|
|
|
|
|
|
||||||||||
|
|
Three Months Ended
|
|||||||
|
June 30,
|
||||||||
|
2025
|
2024
|
|||||||
|
Interest
|
$
|
|
$
|
|
||||
|
Federal income tax
|
|
|
||||||
|
|
Six Months Ended
|
|||||||
|
June 30,
|
||||||||
|
2025
|
2024
|
|||||||
|
Interest
|
$
|
|
$
|
|
||||
|
Federal income tax
|
|
|
||||||
|
June 30, 2025
|
Land, Minerals &
Royalty Interests
|
Exploration
|
Total
|
|||||||||
|
Fixed maturities, at fair value
|
$
|
|
$
|
|
$
|
|
||||||
|
Equity securities, at fair value
|
|
|
|
|||||||||
|
Equity securities, at cost
|
|
|
|
|||||||||
|
Investment real estate
|
|
|
|
|||||||||
|
Notes receivable
|
|
|
|
|||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
||||||
|
December 31, 2024
|
Land, Minerals &
Royalty Interests
|
Exploration
|
Total
|
|||||||||
|
Fixed maturities, at fair value
|
$
|
|
$
|
|
$
|
|
||||||
|
Equity securities, at fair value
|
|
|
|
|||||||||
|
Equity securities, at cost
|
|
|
|
|||||||||
|
Investment real estate
|
|
|
|
|||||||||
|
Notes receivable
|
|
|
|
|||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
||||||
|
As Previously
|
||||||||
|
June 30, 2024
|
Reported
|
|
Adjustments
|
|
As Restated
|
|||
|
Consolidated Statements of Operations
|
||||||||
|
Net investment income
|
$
|
|
$
|
(
|
$
|
|
||
|
Change in fair value of equity securities
|
|
(
|
|
|||||
|
Income tax expense (benefit)
|
|
(
|
|
|||||
|
Net income attributable to common shareholders
|
|
(
|
|
|||||
|
Basic income per share
|
|
(
|
|
|||||
|
Diluted income per share
|
|
(
|
|
|||||
|
Consolidated Statements of Comprehensive Income (Loss)
|
||||||||
|
Net income
|
$
|
|
$
|
(
|
$
|
|
||
|
Unrealized holding gains (losses) arising during the period, pre-tax
|
(
|
|
(
|
|||||
|
Tax (expense) benefit on unrealized holding gains (losses) arising during the period
|
|
(
|
|
|||||
|
Unrealized holding gains (losses) during period, net of tax
|
(
|
|
(
|
|||||
|
Subtotal: Other comprehensive income (loss), net of tax
|
(
|
|
(
|
|||||
|
Consolidated Statements of Cash Flows
|
||||||||
|
Net income
|
$
|
|
$
|
(
|
$
|
|
||
|
Accretion of investments
|
(
|
|
(
|
|||||
|
Change in fair value of equity securities
|
(
|
|
(
|
|||||
|
Change in deferred income taxes
|
|
(
|
|
|
|
Three Months Ended
|
Six Months Ended
|
|||||||||
|
June 30,
|
June 30,
|
||||||||||
|
2025
|
2024
|
2025
|
2024
|
||||||||
|
Net investment income
|
$
|
3,480,217
|
$
|
4,326,467
|
$
|
6,598,953
|
$
|
7,279,849
|
|||
|
Net investment gains
|
$
|
50,999
|
$
|
414,120
|
$
|
1,026,768
|
$
|
451,590
|
|||
|
Change in fair value of equity securities
|
$
|
(1,256,918)
|
$
|
5,362,125
|
$
|
15,033,564
|
$
|
17,738,388
|
|||
|
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
|||||
|
Fixed maturities available for sale
|
$
|
666,237
|
$
|
610,815
|
$
|
1,354,767
|
$
|
1,338,385
|
|
Held to maturity redeemable preferred stock
|
41,171
|
41,171
|
81,890
|
82,342
|
||||
|
Equity securities
|
952,949
|
1,114,329
|
1,678,556
|
1,709,707
|
||||
|
Trading securities
|
-
|
7,301
|
-
|
-
|
||||
|
Mortgage loans
|
238,362
|
209,405
|
459,289
|
418,261
|
||||
|
Real estate
|
1,947,978
|
2,411,441
|
3,613,100
|
4,166,282
|
||||
|
Notes receivable
|
259,748
|
319,262
|
570,677
|
630,684
|
||||
|
Policy loans
|
104,637
|
113,694
|
196,143
|
214,652
|
||||
|
Short-term investments
|
12,432
|
157,910
|
34,838
|
490,515
|
||||
|
Cash and cash equivalents
|
350,248
|
478,120
|
754,892
|
782,947
|
||||
|
Total consolidated investment income
|
4,573,762
|
5,463,448
|
8,744,152
|
9,833,775
|
||||
|
Investment expenses
|
(1,093,545)
|
(1,136,981)
|
(2,145,199)
|
(2,553,926)
|
||||
|
Consolidated net investment income
|
$
|
3,480,217
|
$
|
4,326,467
|
$
|
6,598,953
|
$
|
7,279,849
|
|
|
Three Months Ended
|
Six Months Ended
|
||||||
|
June 30,
|
June 30,
|
|||||||
|
2025
|
2024
|
2025
|
2024
|
|||||
|
Fixed maturities available for sale
|
$
|
412
|
$
|
0
|
$
|
412
|
$
|
0
|
|
Equity securities
|
3,735
|
285,578
|
979,504
|
285,578
|
||||
|
Real estate
|
46,846
|
128,559
|
46,846
|
166,020
|
||||
|
Short-term investments
|
6
|
(17)
|
6
|
(8)
|
||||
|
Consolidated net realized investment gains
|
50,999
|
414,120
|
1,026,768
|
451,590
|
||||
|
Change in fair value of equity securities
|
(1,256,918)
|
5,362,125
|
15,033,564
|
17,738,388
|
||||
|
Net investment gains (losses)
|
$
|
(1,205,919)
|
$
|
5,776,245
|
$
|
16,060,332
|
$
|
18,189,978
|
|
June 30, 2025
|
Amount
|
As a % of Total Investments
|
As a % of Total Assets
|
||||
|
Fixed maturities, available for sale
|
$
|
73,123,864
|
17%
|
14%
|
|||
|
Held to maturity redeemable preferred stock
|
2,500,000
|
1%
|
1%
|
||||
|
Equity securities, at fair value
|
258,785,598
|
61%
|
53%
|
||||
|
Equity securities, at cost
|
20,741,412
|
5%
|
4%
|
||||
|
Mortgage loans
|
15,277,962
|
4%
|
3%
|
||||
|
Real estate
|
28,283,813
|
7%
|
6%
|
||||
|
Notes receivable
|
13,586,824
|
3%
|
3%
|
||||
|
Policy loans
|
5,551,422
|
1%
|
1%
|
||||
|
Short-term investments
|
989,525
|
1%
|
1%
|
||||
|
Total investments
|
$
|
418,840,420
|
100%
|
86%
|
|
December 31, 2024
|
Amount
|
As a % of Total Investments
|
As a % of Total Assets
|
||||
|
Fixed maturities, available for sale
|
$
|
76,480,086
|
19%
|
16%
|
|||
|
Held to maturity redeemable preferred stock
|
2,500,000
|
1%
|
1%
|
||||
|
Equity securities, at fair value
|
234,506,227
|
59%
|
49%
|
||||
|
Equity securities, at cost
|
21,203,393
|
5%
|
4%
|
||||
|
Mortgage loans
|
16,277,981
|
4%
|
3%
|
||||
|
Real estate
|
28,615,602
|
7%
|
6%
|
||||
|
Notes receivable
|
12,672,175
|
3%
|
3%
|
||||
|
Policy loans
|
5,692,565
|
1%
|
1%
|
||||
|
Short-term investments
|
1,954,687
|
1%
|
1%
|
||||
|
Total investments
|
$
|
399,902,716
|
100%
|
84%
|
|
Exhibit Number
|
Description
|
|
*
31.1
|
Certification of Jesse T. Correll, Chief Executive Officer and Chairman of the Board of UTG, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
*
31.2
|
Certification of Theodore C. Miller, Chief Financial Officer and Senior Vice President of UTG, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
*
32.1
|
Certificate of Jesse T. Correll, Chief Executive Officer and Chairman of the Board of UTG, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
*
32.2
|
Certificate of Theodore C. Miller, Chief Financial Officer and Senior Vice President of UTG, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
**101
|
The following financial statements from the Quarterly Report on Form
10
-Q for the quarter ended
June 30, 2025
, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Balance Sheets, (ii) Condensed
Consolidated
Statements of Operations, (iii) Condensed
Consolidated
Statements of Comprehensive Income, (iv)
Condensed Consolidated Statements of Shareholders' Equity
, (v)
Condensed Consolidated Statements of Cash Flows
and (vi) Notes to the Condensed Consolidated Financial Statements (detail tagged).
|
|
**104
|
Cover Page Interactive Data File (formatted in iXBRL and included in exhibit
101
).
|
|
Date:
|
August 12, 2025
|
|
By
|
/s/ Jesse T. Correll
|
|
|
|
|
|
Jesse T. Correll
|
|
|
|
|
|
Chairman of the Board, Chief Executive Officer, President and Director (Principal Executive Officer)
|
|
Date:
|
August 12, 2025
|
|
By
|
/s/ Theodore C. Miller
|
|
|
|
|
|
Theodore C. Miller
|
|
|
|
|
|
Chief Financial Officer and Senior Vice President
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|